Cardiometabolic Risk Factors in Adolescents with Polycystic Ovary Syndrome

Author(s): Anastasia Vatopoulou*, Maria-Eleni Dionelli, Alexis Papanikolaou, Sonia Grover

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 36 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

It is well-established that adults with polycystic ovary syndrome (PCOS) have an increased prevalence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus, and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present review summarizes the existing evidence regarding the prevalence of traditional and non-traditional cardiometabolic risk factors in adolescents with PCOS.

Keywords: Polycystic ovary syndrome, adolescence, obesity, type 2 diabetes mellitus, hyperandrogenemia, anovulation.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 36
Year: 2021
Published on: 27 November, 2020
Page: [3808 - 3811]
Pages: 4
DOI: 10.2174/1381612826666201127123357
Price: $65

Article Metrics

PDF: 281